PharmaLytica 2021 Hyderabad review.

Commitment to partner with the Government of India to make the vaccine available in the country: Pfizer

December 05, 2020

Global pharma major Pfizer, on Thursday, said that it remains committed to engaging with the Indian government to explore opportunities to make Pfizer/BioNTech vaccine available in the country. On Wednesday, the UK became the first country to approve Pfizer/BioNTech against COVID-19. The Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom has granted temporary approval for its emergency use.

"Right now we are in discussions with many governments around the world and remain committed to engaging with the Government of India and explore opportunities to make this vaccine available for use in the country," a Pfizer spokesperson said in a statement.

Pfizer is committed to ensuring everyone has the opportunity to have access to the vaccine, and is working closely with governments, it added.

"During this pandemic phase, Pfizer will supply this vaccine only through government contracts based on agreements with respective government authorities and following regulatory authorisation or approval," the statement said.

The United Kingdom's regulator, MHRA, has issued a temporary authorization for the emergency use of the COVID-19 mRNA vaccine.


This Website Uses Cookies for Google Analytics, to improve your experience and to show you personalized advertising. By using this website you agree to our COOKIES AND PRIVACY POLICY...Learn More